Cure or Curse: Exposing the Pharmaceutical Mafia and the Poison in Our Veins
In the corridors of Pakistan’s healthcare system, a silent epidemic thrives not of disease itself, but of a profit‑driven machinery that turns life-saving medicine into a commodity, and patients into expendable vessels. Antibiotics, intended to cure, have become instruments of a quiet poisoning, flowing freely from medical stores into the hands of those who cannot afford the luxury of a doctor’s consultation. Despite regulations that on paper promise rigorous licensing, accreditation, and ethical distribution, the real drivers of access are not merit or safety, but nepotism, favoritism, and the invisible strings of influence that dictate which medicines reach shelves and which remain locked away. In this system, compliance is performative, rules exist to be bypassed, and the supposed guardians of public health watch as the veins of the nation fill with unchecked remedies.
The problem begins with economic reality. A patient entering a clinic faces a choice between financial survival and proper medical guidance. Doctor’s consultation fees are beyond reach for the majority, particularly in rural or low-income urban areas. The cost of a single visit can equal weeks of wages, prompting desperate individuals to seek alternatives in the easiest form available the antibiotic aisle of local medical stores. Here, pills and capsules, ostensibly powerful weapons against infection, are sold freely, often without prescriptions, guidance, or quality checks. What should be a controlled, life-saving intervention becomes an unsupervised gamble: the dose may be wrong, the antibiotic may be inappropriate, and the body’s response becomes a field experiment conducted on the unwitting patient.
This culture of self-medication is both a symptom and a perpetuation of systemic decay. The licensing policies designed to safeguard medicine distribution are theoretically strict. Licenses are conditional, inspections are mandated, and regulatory standards are codified. In reality, these safeguards are circumvented by networks of influence, nepotism, and informal relationships. Compliance is secondary to connection; meritocracy is eclipsed by favoritism. A pharmacist’s right to dispense, a distributor’s right to supply, or even a medical store’s permission to operate often depends less on capability or ethical adherence and more on whom one knows, who greases the wheels, and who turns a blind eye to violations. The system that should protect patients becomes a mirror reflecting the very inequalities it claims to prevent.
The consequences of this malpractice are visible in the bodies of the people. Overuse and misuse of antibiotics create resistance, weaken immune systems, and sometimes introduce toxins directly into human circulation. Injections and drips, often administered as status symbols of “active treatment,” are not neutral interventions but profit‑driven instruments. Drip culture has emerged as a tangible metaphor for exploitation: the needle is the conduit, the saline the currency, and the patient the unwitting contributor to a multi-layered chain of profit. Hospitals, clinics, and medical stores earn while bodies burn a cruel calculus where the fee for comfort, the appeal of rapid relief, and the show of medical attention outweigh true healing.
This is compounded by the economic pressures on patients. Faced with daily survival, the patient negotiates with the market rather than with medical necessity. The choice of antibiotic without consultation is an act of survival a compromise dictated by the unendurable cost of proper treatment. Drips, injections, and pills become symbolic of both hope and burden, with the veins of the population carrying the price of systemic failure, both economic and ethical. In essence, the cure has become a curse: the very interventions meant to heal are administered in a way that prioritizes profit over human welfare.
Society bears the consequences in ways that are both immediate and generational. Resistance to antibiotics spreads, infections persist longer, and treatment failures increase. The healthcare system, meant to nurture and protect, has been transformed into a machine that monetizes desperation. Patients pay not only with money but with time, health, and sometimes life itself. The metaphor of pleura running in the veins captures this grim reality: every drip, every injection, every pill dispensed under informal, profit-oriented supervision carries within it both the potential for healing and the risk of harm. The market thrives on the tension between need and affordability, and the most vulnerable are the ones whose blood and bodies bear the evidence.
Awareness is urgently needed. Stakeholders regulators, policy-makers, civil society, and the medical fraternity must confront the reality that the pharmaceutical chain has been corrupted from end to end. Licensing must be enforced with integrity, dispensing practices must be monitored rigorously, and economic access to qualified doctors must be made feasible, otherwise the cycle will continue. Until systemic reforms are enacted, the veins of the nation will continue to carry both the promise of cure and the poison of exploitation, and every patient will remain a silent witness to the commodification of health.
A Public Service Message
